Genetic aspects of prostate cancer

被引:40
作者
Latil, A
Lidereau, R
机构
[1] Ctr Rene Huguenin, Lab Oncogenet, F-92210 St Cloud, France
[2] INSERM, Paris, France
关键词
prostate cancer; oncogenes; tumour suppressor gene; loss of heterozygosity; fluorescence in situ hybridization; comparative genomic hybridization;
D O I
10.1007/s004280050183
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Despite its high incidence and mortality rate, the molecular mechanisms underlying the oncogenesis and progression of prostate cancer are still unclear. This review, based on recently published data, surveys the current state of knowledge of human prostate oncogenesis, dealing with genetic predisposition in familial clusters of prostate cancer, providing new information on the somatic genetic alterations, which have been approached in four ways (measurement of DNA content, cytogenetic analysis, in situ hybridization, and molecular analysis), and investigating the problems of androgen independence and intratumour heterogeneity in prostate tumours. Lastly, the potential clinical applications of the genetic alterations, which may become important in the near future, are addressed.
引用
收藏
页码:389 / 406
页数:18
相关论文
共 243 条
[1]  
ALCARAZ A, 1994, CANCER RES, V54, P3998
[2]   INTERPHASE CYTOGENETICS OF PROSTATIC ADENOCARCINOMA AND PRECURSOR LESIONS - ANALYSIS OF 25 RADICAL PROSTATECTOMIES AND 17 ADJACENT PROSTATIC INTRAEPITHELIAL NEOPLASIAS [J].
ALERS, JC ;
KRIJTENBURG, PJ ;
VISSERS, KJ ;
BOSMAN, FT ;
VANDERKWAST, TH ;
VANDEKKEN, H .
GENES CHROMOSOMES & CANCER, 1995, 12 (04) :241-250
[3]  
ALEXANDROW MG, 1995, CANCER RES, V55, P1452
[4]  
ANWAR K, 1992, CANCER RES, V52, P5991
[5]   FAMILY HISTORY AND THE RISK OF PROSTATIC-CARCINOMA IN A HIGH-RISK GROUP OF UROLOGICAL PATIENTS [J].
APRIKIAN, AG ;
BAZINET, M ;
PLANTE, M ;
MESHREF, A ;
TRUDEL, C ;
ARONSON, S ;
NACHABE, M ;
PELOQUIN, F ;
DESSUREAULT, J ;
NAROD, S ;
BEGIN, L ;
ELHILALI, MM .
JOURNAL OF UROLOGY, 1995, 154 (02) :404-406
[6]   IMMUNOHISTOCHEMICAL DETERMINATION OF P53 PROTEIN NUCLEAR ACCUMULATION IN PROSTATIC ADENOCARCINOMA [J].
APRIKIAN, AG ;
SARKIS, AS ;
FAIR, WR ;
ZHANG, ZF ;
FUKS, Z ;
CORDONCARDO, C .
JOURNAL OF UROLOGY, 1994, 151 (05) :1276-1280
[7]  
ARASON A, 1993, AM J HUM GENET, V52, P711
[8]  
AVERY A, 1992, HUM PATHOL, V23, P368
[9]   TRISOMY-7 - A POTENTIAL CYTOGENETIC MARKER OF HUMAN PROSTATE-CANCER PROGRESSION [J].
BANDYK, MG ;
ZHAO, L ;
TRONCOSO, P ;
PISTERS, LL ;
PALMER, JL ;
VONESCHENBACH, AC ;
CHUNG, LWK ;
LIANG, JC .
GENES CHROMOSOMES & CANCER, 1994, 9 (01) :19-27
[10]   Thymosin beta 15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer [J].
Bao, LR ;
Loda, M ;
Janmey, PA ;
Stewart, R ;
AnandApte, B ;
Zetter, BR .
NATURE MEDICINE, 1996, 2 (12) :1322-1328